{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:29:37Z","timestamp":1791383377062,"version":"4.3.3"},"reference-count":16,"publisher":"The Journal of Rheumatology","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the involvement of intraarticular (IA) infliximab (IFX) in the management of temporomandibular joint (TMJ) arthritis associated with juvenile idiopathic arthritis (JIA) that is refractory to systemic treatment and IA corticosteroid therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Ours was a retrospective study of children with JIA who received IA IFX into the TMJ. The effectiveness of treatment on the progression of acute and chronic changes was assessed by a quantitative magnetic resonance imaging scoring system.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Median acute and chronic scores worsened by 0.25 and 0.75, respectively. In multivariate analysis, worsening acute scores and passage of time predicted worsening of the chronic scores.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>IA IFX allowed for progression of refractory TMJ arthritis in most but not all children with JIA.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.150308","type":"journal-article","created":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T01:23:46Z","timestamp":1441157026000},"page":"2155-2159","source":"Crossref","is-referenced-by-count":22,"title":["Magnetic Resonance Imaging Findings following Intraarticular Infliximab Therapy for Refractory Temporomandibular Joint Arthritis among Children with Juvenile Idiopathic Arthritis"],"prefix":"10.3899","volume":"42","author":[{"given":"Matthew Laurence","family":"Stoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoginder Nath","family":"Vaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Beukelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Daniel","family":"Waite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy Quentin","family":"Cron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"key":"2018112909345978000_42.11.2155.1","doi-asserted-by":"publisher","DOI":"10.1097\/01.bor.0000240360.24465.4c"},{"key":"2018112909345978000_42.11.2155.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23401"},{"key":"2018112909345978000_42.11.2155.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2011.11.003"},{"key":"2018112909345978000_42.11.2155.4","first-page":"1157","article-title":"Intraarticular corticosteroid injections of the temporomandibular joint in juvenile idiopathic arthritis","volume":"35","author":"Ringold","year":"2008","journal-title":"J Rheumatol"},{"key":"2018112909345978000_42.11.2155.5","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.04.1103"},{"key":"2018112909345978000_42.11.2155.6","doi-asserted-by":"publisher","DOI":"10.1002\/art.21384"},{"key":"2018112909345978000_42.11.2155.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00247-010-1581-2"},{"key":"2018112909345978000_42.11.2155.8","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes318"},{"key":"2018112909345978000_42.11.2155.9","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22177"},{"key":"2018112909345978000_42.11.2155.10","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909345978000_42.11.2155.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.11.003"},{"key":"2018112909345978000_42.11.2155.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111441"},{"key":"2018112909345978000_42.11.2155.13","doi-asserted-by":"publisher","DOI":"10.1037\/h0026256"},{"key":"2018112909345978000_42.11.2155.14","doi-asserted-by":"publisher","DOI":"10.1111\/ocr.12008"},{"key":"2018112909345978000_42.11.2155.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.20979"},{"key":"2018112909345978000_42.11.2155.16","first-page":"1934","article-title":"Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?","volume":"33","author":"Fisher","year":"2006","journal-title":"J Rheumatol"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.150308","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T18:58:56Z","timestamp":1543517936000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.150308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":16,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,1]]},"published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.3899\/jrheum.150308"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.150308","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,1]]}}}